
Keywords: تعیین صلاحیت; watchful waiting; prostatic neoplasms; eligibility determination; AS; active surveillance; B2; confirmatory biopsy (second biopsy); BCR; biochemical recurrence; GS; Gleason score; JH; Johns Hopkins; MSK; Memorial Sloan Kettering Cancer Center; PCa; prosta